Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

50.55
Delayed Data
As of Oct 20
 -0.13 / -0.26%
Today’s Change
30.89
Today|||52-Week Range
50.95
+40.96%
Year-to-Date

Today’s Trading

Previous close50.68
Today’s open50.68
Day’s range50.37 - 50.69
Volume1,004,169
Average volume (3 months)1,903,110
Market cap$99.4B
Dividend yield2.26%
Data as of 4:02pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)+3.81%
P/E ratio3.3
Price/Sales5.48
Price/Book19.71

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.32+0.57%
LLYEli Lilly and Co+0.87+1.01%
BMYBristol-Myers Squibb-0.25-0.39%
GSKGlaxoSmithKline-0.26-0.63%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.60
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts